DalsnaFinance

Certara $CERT

Health Care

Russell 2000 Pennsylvania
Create a scorecard

Live price temporarily unavailable.

Price history
Loading chart…
Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Sep 30, 2026, the first target we tracked for CERT.

Certara (CERT) is a Health Care company in the Russell 2000. Latest news and coverage below.

IPO: December 11, 2020 · $23.00 offering · NASDAQ · View IPO details →

Analyst price targets on CERT

One firm's current price target on Certara: $10. Each is tracked to its date and scored the same way a member's call is.

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Certara revenue & net income history (FY2019–FY2025)

RevenueNet incomeNet margin (right axis, %)
$418.8M$181.7M−$55.4MFY2019 revenue: $208.5MFY2019 net income: −$8.93M · Net margin −4.3%'19FY2020 revenue: $243.5MFY2020 net income: −$49.4M · Net margin −20.3%'20FY2021 revenue: $286.1MFY2021 net income: −$13.3M · Net margin −4.6%'21FY2022 revenue: $335.6MFY2022 net income: $14.7M · Net margin 4.4%'22FY2023 revenue: $354.3MFY2023 net income: −$55.4M · Net margin −15.6%'23FY2024 revenue: $385.1MFY2024 net income: −$12.1M · Net margin −3.1%'24FY2025 revenue: $418.8MFY2025 net income: −$1.59M · Net margin −0.4%'25−2.6%0%5%10%15%20%FY2019 net margin: −4.3% (off the scale, which stops at −2.6%)FY2020 net margin: −20.3% (off the scale, which stops at −2.6%)FY2021 net margin: −4.6% (off the scale, which stops at −2.6%)FY2022 net margin: 4.4%FY2023 net margin: −15.6% (off the scale, which stops at −2.6%)FY2024 net margin: −3.1% (off the scale, which stops at −2.6%)FY2025 net margin: −0.4%
Certara annual financial statements
FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue$208.5M$243.5M$286.1M$335.6M$354.3M$385.1M$418.8M
Growth (year over year)—+16.8%+17.5%+17.3%+5.6%+8.7%+8.7%
Gross profit$128.7M$142.8M$174.5M$203.1M$213.3M$230.6M$257.7M
Gross margin61.7%58.6%61.0%60.5%60.2%59.9%61.5%
Operating income$19.6M−$24.4M$13.6M$32.5M−$40.8M−$1.73M$21.0M
Operating margin9.4%−10.0%4.7%9.7%−11.5%−0.4%5.0%
Net income−$8.93M−$49.4M−$13.3M$14.7M−$55.4M−$12.1M−$1.59M
Net margin−4.3%−20.3%−4.6%4.4%−15.6%−3.1%−0.4%
EPS (diluted)−$0.07−$0.37−$0.09$0.09−$0.35−$0.08−$0.01
Balance sheet
Cash and equivalents$29.3M$271.4M$185.8M$236.6M$235.0M$179.2M$189.4M
Total assets—$1.27B$1.51B$1.57B$1.56B$1.58B$1.56B
Total liabilities—$447.3M$469.9M$493.3M$516.3M$516.4M$493.8M
Long-term debt—$294.1M$291.7M$290.0M$288.2M$292.4M$290.1M
Shareholders' equity$492.0M$822.1M$1.04B$1.08B$1.05B$1.06B$1.06B
Cash flow
Operating cash flow$38.0M$44.8M$60.4M$92.5M$82.8M$80.5M$96.3M
Capital expenditure$2.11M$863.0K$1.14M$1.43M$1.78M$1.63M$1.76M
Free cash flow$35.9M$43.9M$59.2M$91.1M$81.0M$78.8M$94.6M
Share buybacks$703.0K$1.08M——$0$0$42.6M

From Certara's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Certara

Headquarters
Radnor, Pennsylvania From SEC filings, Oct 2026

Recent News (2)

More Health Care stocks

Browse all companies →